Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Family and General Medicine Practitioners
Family and General Medicine Practitioners Family and General Medicine Practitioners

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Family Medicine Conferences &
Educational Opportunities









Dec. 27, 2020 - 31

Skin, Bones, Hearts & Private Parts - CME NOW OnDemand

Skin, Bones, Heart & Private Parts

July 28 - 28, 2022

Primary Care Focus Symposium Online

Baptist Health South Florida

More Events

Antacids May Improve Blood Sugar Control In People With Diabetes | NEWS-Line for Family and General Medicine Practitioners
 


Antacids May Improve Blood Sugar Control In People With Diabetes


Source:

Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to a new meta-analysis published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Type 2 diabetes is a global public health concern affecting almost 10 percent of people worldwide. Doctors may prescribe diet and lifestyle changes, diabetes medications, or insulin to help people with diabetes better manage their blood sugar, but recent data points to common over the counter antacid medicines as another way to improve glucose levels.

"Our research demonstrated that prescribing antacids as an add-on to standard care was superior to standard therapy in decreasing hemoglobin A1c (HbA1c) levels and fasting blood sugar in people with diabetes,” said study author Carol Chiung-Hui Peng, M.D., of the University of Maryland Medical Center Midtown Campus in Baltimore, Md.

“For people without diabetes, taking antacids did not significantly alter their risk of developing the disease,” said study author, Huei-Kai Huang M.D., of the Hualien Tzu Chi Hospital in Hualien, Taiwan.

The researchers performed a meta-analysis on the effects of proton pump inhibitors (PPIs)—a commonly used type of antacid medication—on blood sugar levels in people with diabetes and whether these medications could prevent the new onset of diabetes in the general population. The analysis included seven studies (342 participants) for glycemic control and 5 studies (244, 439 participants) for risk of incident diabetes. The researchers found antacids can reduce HbA1c levels by 0.36% in people with diabetes and lower fasting blood sugar by 10 mg/dl based on the results from seven clinical trials. For those without diabetes, the results of the five studies showed that antacids had no effect on reducing the risk of developing diabetes.

“People with diabetes should be aware that these commonly used antacid medications may improve their blood sugar control, and providers could consider this glucose-lowering effect when prescribing these medications to their patients,” said study author Kashif Munir, M.D., associate professor in the division of endocrinology, diabetes and nutrition at the University of Maryland School of Medicine in Baltimore, Md.

Other authors of the study include: Yuting Huang and Khulood Bukhari of the University of Maryland Medical Center Midtown Campus in Baltimore, Md.; Yu-Kang Tu of the National Taiwan University and the Taipei Medical University in Taipei, Taiwan; Gin Yi Lee of the Danbury Hospital in Danbury, Conn.; Rachel Huai-En Chang of the Johns Hopkins Bloomberg School of Public Health in Baltimore, Md.; Yao-Chou Tsai of the Taipei Medical University; Yunting Fu of the University of Maryland in Baltimore, Md.

The manuscript received no external funding.

The manuscript, “Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis,” was published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia

Source: The Endocrine Society






Share This!


Family Medicine Jobs




Nurse Practitioner - Genetics

University Pediatricians
Detroit, Michigan

Nurse Practitioner - Hematology Oncology

University Pediatricians
Detroit, Michigan

Speech/Language Pathologists,

Shield Institute
Bronx, New York

• Instructor/Assistant Professor, Nursing • Instructor/Assistant Professor, Histotechnology • Instructor/Assistant Professor & Academic Chair, Medical Assisting

Anne Arundel Community College
Maryland

• Instructor/Assistant Professor, Nursing • Instructor/Assistant Professor, Histotechnology • Instructor/Assistant Professor & Academic Chair, Medical Assisting

Anne Arundel Community College
Faculty

Advanced Practice Clinicians (NP or PA) - Salary 100K plus CME and Benefits Package

Hampshire Gastroenterology
Northampton, Massachusetts

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.